2m 2m 2m 2m 2m 2m 2m
ABVC BIOPHARMA (ABVC)
NASDAQ
$1.03+$0.01 (+1.49%)
Price as of Aug 03, 2026 11:30 AM EDT- $26.3MMarket Cap
- -63.27%1-Year Change
- BiotechnologyIndustry
ABVC BIOPHARMA (ABVC)
$1.03+$0.01 (+1.49%)
ABVC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.01 | ||
Change | -$0.07 (-6.48%) | ||
Open | $1.08 | ||
High | $1.08 | ||
Low | $1.01 | ||
Previous Close | $1.08 | ||
Volume | 25,436 | ||
30-Day Average Volume | 158,277 | ||
1-Week Change | -12.17% | ||
1-Month Change | -36.08% | ||
1-Year Change | -63.27% | ||
3-Year Change | -59.44% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.0M | ||
Total Assets | $19.7M | ||
Market Cap | $26.3M | ||
Enterprise Value | $26.6M | ||
Period: QTR TTM FY | |||
Revenue | -$1,168.00 | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$894,243.00 | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | -$4.7M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | -22,773 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | -0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2023 | ||
Earnings & Revenue